ClinVar Miner

Submissions for variant NM_002471.4(MYH6):c.4360-7C>G

dbSNP: rs58949384
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000154757 SCV000204437 uncertain significance not specified 2014-06-05 criteria provided, single submitter clinical testing The 4360-7C>G variant in MYH6 has not been previously reported in individuals wi th cardiomyopathy or in large population studies. This variant is located in the 3' splice region. Computational tools do not suggest an impact to splicing. How ever, this information is not predictive enough to rule out pathogenicity. In su mmary, the clinical significance of the 4360-7C>G variant is uncertain.
Labcorp Genetics (formerly Invitae), Labcorp RCV000647092 SCV000768879 benign Hypertrophic cardiomyopathy 14 2024-01-13 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV001657880 SCV001473856 uncertain significance not provided 2020-01-16 criteria provided, single submitter clinical testing The MYH6 c.4360-7C>G variant (rs58949384), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 178067). This variant is found in the African population with an allele frequency of 0.13% (32/24706 alleles) in the Genome Aggregation Database. This is an intronic variant in a moderately conserved nucleotide, and computational analyses (Alamut v.2.11) predict that this variant may impact splicing by weakening the nearby canonical acceptor splice site. However, without functional studies, the effect on splicing is unknown. Due to limited information, the clinical significance of the c.4360-7C>G variant is uncertain at this time.
GeneDx RCV001657880 SCV001872782 likely benign not provided 2024-04-08 criteria provided, single submitter clinical testing See Variant Classification Assertion Criteria.
PreventionGenetics, part of Exact Sciences RCV004734725 SCV005350784 likely benign MYH6-related disorder 2024-06-26 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.